Menu
Back to Journals » Vascular Health and Risk Management » Volume 12
Review
Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 41,978 | Dovepress* | 14,375+ | 3,079 | 17,454 | |
| PubMed Central* | 27,603 | 5,264 | 32,867 | ||
| Totals | 41,978 | 8,343 | 50,321 | ||
|
*Since 17 February 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 30 | 0 | 0 | 0 | 14 | 16 |
View citations on PubMed Central and Google Scholar